|
Accueil > Actualité
J&J: presenting series of abstracts on myasthenia gravis
(CercleFinance.com) - Johnson & Johnson announces that 25 abstracts will be presented at two medical events (i.
e., American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA), on 15-18 October 2024) concerning generalized myasthenia gravis (gMG) and the evaluation of the investigational treatment nipocalimab. Sixteen of these abstracts will be shared at the MGFA Scientific Session, including three oral presentations on nipocalimab. These studies show positive results in adolescents and adults with gMG, with early and lasting improvements. The presentations also address the impact of the disease on daily life and the challenges of managing gMG. Copyright (c) 2024 CercleFinance.com. All rights reserved. |
04/10/2024 17:11
Wendeltitre en hausse, un broker relève sa cible 04/10/2024 17:01 Metal'UE limite l'usage des données pour la pub ciblée 04/10/2024 16:40 Clasquinfeu vert de Bruxelles au rachat par MSC 04/10/2024 16:31 BAE Systemscontrat de 92 M$ auprès de l'US Navy 04/10/2024 16:11 Sanoficession d'un anti-anémique à l'italien Recordati 04/10/2024 16:00 EngieBlackRock sous les 5% du capital Tous les articles sociétés |
